skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration

What major drug catalysts and events can you expect to see this quarter?

Download your free Biomedtracker/Meddevicetracker Q4 2019 Outlook Report, a data driven assessment of the likelihood of approval for an array of drugs. 

Get a view of what’s to come with an extract from the full report, containing:

• Data for 33 drugs, diagnostics, and devices
• Likelihood of Phase/PDUFA review success for each
• Q4 expected large impact catalysts
• A look back at the outcomes from the Q3 Outlook report
• Overall Likelihood of Approval (LOA) based on phase, drug class, and disease group
• Benchmarking data from Pharmapremia

JN2646_Cov_Ima_Q4_2019_Outlook_Report_Extract
Download now

Read also

  • Biomedtracker: see the drug development process through anal...

    Key Potential Drug Launches in 2022

    Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.

    Single Report

  • Biomedtracker: see the drug development process through anal...

    2020 Deal-Making Roundup

    Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

    Topics Drug Review Coronavirus

    View white paper

  • Biomedtracker: see the drug development process through anal...

    Q3 2021 Outlook Report

    What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

    Topics Drug Review

    Single Report
;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Request a free trial

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now